Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for HYUNDAI FEED Inc. (016790:KRX), powered by AI.
HYUNDAI FEED Inc. is currently trading at ₩994. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for HYUNDAI FEED Inc. on Alpha Lenz.
HYUNDAI FEED Inc.'s P/E ratio is 42.7.
“HYUNDAI FEED Inc. trades at a P/E of 42.7 (premium valuation) with modest ROE of 5.3%.”
Ask for details →HYUNDAI FEED Inc. engages in the manufacture and sale of formulated feed. Its primary products include poultry and pig feed. The company also engages in the biopharmaceutical business. In addition, it focuses on the development and commercialization of immunotherapies for cancer. Further, the company's lead product includes oregovomab, an immunotherapy for ovarian cancer. Additionally, it is involved in the developing AR20.5, which treatment of pancreatic cancer. The company was formerly known as CANARIABIO Inc. and changed to HYUNDAI FEED Inc. on January 2024. The company was founded in 1983 and is headquartered in Seoul, South Korea.
“HYUNDAI FEED Inc. trades at a P/E of 42.7 (premium valuation) with modest ROE of 5.3%.”
Ask for details →HYUNDAI FEED Inc. (ticker: 016790) is a company listed on KRX in the Consumer Defensive sector (Packaged Foods). It has approximately 86 employees. Market cap is $187.3B.
The current price is ₩994 with a P/E ratio of 42.73x and P/B of 2.45x.
ROE is 5.30% and operating margin is 4.42%. Annual revenue is $113.0B.